Pharmacy Medical News

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bayer submits first-in-class estradiol-based oral contraceptive for approval in the U.S.
BayNews International, 07/09/09

Bayer has submitted a New Drug Application to the U.S. Food and Drug Administration for a new estradiol-based oral contraceptive. It seeks approval for the indications oral contraception and treatment of heavy and/or prolonged menstrual bleeding. The new product with an estradiol valerate/dienogest combination is the first in a new class of oral contraceptives to deliver estradiol, the estrogen identical to the one produced by the female body. It is marketed in Europe under the tradename Qlaira.

<< Previous
FDA Boosts Warnings on Propoxyphene Pain Meds

Next >>
Cost implications of IV versus oral anti-angiogenesis therapies...